• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Practice Fusion Appoints Interim CEO, Replacing Ryan Howard to Drive Next Phase of Growth

by HITC Staff 08/17/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Practice Fusion Ryan Howard

Practice Fusion, a cloud-based EHR platform for doctors and patients has appointed Tom Langan, the current chief commercial officer, as interim CEO of the company, replacing Ryan Howard who will assume the position of Chairman of the Board. While the move to replace Howard seems abrupt, the Board of Directors felt the leadership transition was the best step to help the company accelerate commercial growth of its EHR platform.

Tom Langan joined Practice Fusion from Symphony Health Solutions, where he served as its chief commercial officer responsible for managing the growth of the health care data, analytics, and consulting businesses and also previously served as the chief commercial officer of MediMedia. Over the last year, Tom has been critical to driving the company’s vision of a connected health care ecosystem by bringing new opportunities for collaboration with key industry partners and clients, as well as launching and developing new products such as medication adherence, clinical decision support, real world evidence studies, life science marketing and enterprise solutions, and new population health management (PHM) programs in the areas of weight management, asthma, COPD, diabetes, and other chronic conditions.

Imminent IPO

In an interview with the Wall Street Journal, Langan declined to clarify if his appointment to interim CEO is a signal for imminent IPO, stating the company is simply “focusing on putting the appropriate elements in place” for the next stage of growth. The statement backs up former CEO Ryan Howard’s recent interview with us last month, saying, “Practice Fusion is the most viable company in the digital health space to go public and are looking forward to an IPO when we are ready for it.”

The company recently hired four new members to its leadership team:Matt Ackley as Chief Marketing Officer; Dorothy Gemmell as Senior Vice President, Life Science Practice and Strategic Partnerships; Tim Rauschenbach as Vice President, Customer Service and Support; andDave Caldwell as Senior Vice President, Enterprise Solutions. Additionally, Alan Black has joined Practice Fusion’s Board of Directors as its newest director, and will also serve as the Chairperson of the Audit Committee.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: practice fusion

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |